GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Argent Biopharma Ltd (ASX:RGT) » Definitions » Days Sales Outstanding

Argent Biopharma (ASX:RGT) Days Sales Outstanding : 71.61 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Argent Biopharma Days Sales Outstanding?

Argent Biopharma's average Accounts Receivable for the six months ended in Dec. 2023 was A$0.37 Mil. Argent Biopharma's Revenue for the six months ended in Dec. 2023 was A$0.94 Mil. Hence, Argent Biopharma's Days Sales Outstanding for the six months ended in Dec. 2023 was 71.61.

The historical rank and industry rank for Argent Biopharma's Days Sales Outstanding or its related term are showing as below:

ASX:RGT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.58   Med: 60.94   Max: 150.79
Current: 137.64

During the past 13 years, Argent Biopharma's highest Days Sales Outstanding was 150.79. The lowest was 47.58. And the median was 60.94.

ASX:RGT's Days Sales Outstanding is ranked worse than
88.24% of 995 companies
in the Drug Manufacturers industry
Industry Median: 71.56 vs ASX:RGT: 137.64

Argent Biopharma's Days Sales Outstanding increased from Dec. 2022 (64.63) to Dec. 2023 (71.61).


Argent Biopharma Days Sales Outstanding Historical Data

The historical data trend for Argent Biopharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argent Biopharma Days Sales Outstanding Chart

Argent Biopharma Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 150.79 47.58 103.60 60.94 51.07

Argent Biopharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.93 112.90 64.63 170.67 71.61

Competitive Comparison of Argent Biopharma's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Argent Biopharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Argent Biopharma's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Argent Biopharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Argent Biopharma's Days Sales Outstanding falls into.



Argent Biopharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Argent Biopharma's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

Days Sales Outstanding (A: Jun. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2022 ) + Accounts Receivable (A: Jun. 2023 )) / count ) / Revenue (A: Jun. 2023 )*Days in Period
=( (0.739 + 0.209) / 2 ) / 3.388*365
=0.474 / 3.388*365
=51.07

Argent Biopharma's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.209 + 0.531) / 2 ) / 0.943*365 / 2
=0.37 / 0.943*365 / 2
=71.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Argent Biopharma  (ASX:RGT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Argent Biopharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Argent Biopharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Argent Biopharma (ASX:RGT) Business Description

Traded in Other Exchanges
Address
295 Rokeby Road, Suite 1, Subiaco, WA, AUS, 6008
MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy at the forefront of the emerging phytocannabinoid and plant-derived medicine markets. The company's mission is to build an innovative, global bio-pharma company providing standardized, affordable plant-derived medicines of the highest regulatory compliance for targeted global markets.

Argent Biopharma (ASX:RGT) Headlines

From GuruFocus

Royce Global Value Trust (NYSE: RGT) as of Feb 28, 2023

By PRNewswire PRNewswire 03-28-2023

Royce Global Value Trust (NYSE: RGT) as of Dec 31, 2021

By PRNewswire PRNewswire 01-31-2022

Royce Global Value Trust (NYSE: RGT) as of Apr 30, 2022

By PRNewswire PRNewswire 06-03-2022

Royce Global Value Trust (NYSE: RGT) as of Apr 30, 2022

By PRNewswire PRNewswire 06-13-2022

Royce Global Value Trust (NYSE: RGT) as of Sep 30, 2022

By PRNewswire PRNewswire 10-28-2022

Royce Global Value Trust (NYSE: RGT) as of Apr 30, 2022

By PRNewswire PRNewswire 06-23-2022

Royce Global Value Trust (NYSE: RGT) as of Apr 30, 2022

By PRNewswire PRNewswire 07-13-2022

Royce Global Value Trust (NYSE: RGT) as of Dec 31, 2022

By PRNewswire PRNewswire 01-25-2023